Clinical Trial Update: A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and efficacy study of intravenous 131I-TM601 in adults with malignant melanoma was conducted, but the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• 131I-TM601 (TM601)

Snippet

Sponsor: TransMolecular | Conditions: Melanoma, Malignant Melanoma | Phase 1, Phase 2 | Status: TERMINATED